• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

BioTime Inc.

economics regenerative medicine stemells tissue engineering regmed

  • Please log in to reply
777 replies to this topic

#61 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 06 October 2011 - 01:21 PM

Do you beleive in Cell Therapy yet?
MarketWatch - 13 hours ago
Oct 06, 2011 (ACCESSWIRE-TNW via COMTEX) -- Are you convinced that Cell Therapy is a viable process which can be used to treat diseases? In a recent press release, dated September 26, 2011, the ...

View the full article

#62 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 07 October 2011 - 02:55 PM

Biotechs Placing Bets On Cell Therapy Success
Seeking Alpha - 2 hours ago
Are you convinced that cell therapy is a viable process which can be used to treat diseases? In a recent press release, dated September 26, 2011, Lonza agreed to construct a manufacturing facility ...

View the full article

#63 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 10 October 2011 - 12:46 PM

BioTime CEO Michael D. West to Present at GTC 2011 5th Advances in Stem Cell Discovery & Development Conference
MarketWatch - 19 hours ago
ALAMEDA, Calif., Oct 10, 2011 (BUSINESS WIRE) -- BioTime, Inc. /quotes/zigman/219441/quotes/nls/btx BTX +5.77% , a biotechnology company that develops and markets products in the field of ...
BioTime CEO Michael D. West To Present At GTC 2011 5th Advances In Stem Cell Discovery & Development Conference - TheStreet.com

View the full article

sponsored ad

  • Advert

#64 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 13 October 2011 - 12:47 PM

BioTime Publishes Paper Describing First Complete Sequencing of the Nuclear DNA of Five Clinical-Grade Human Embryonic Stem Cell Lines
MarketWatch - 10 hours ago
ALAMEDA, Calif., Oct 13, 2011 (BUSINESS WIRE) -- BioTime, Inc. /quotes/zigman/219441/quotes/nls/btx BTX +0.22% announced today the publication in the peer-reviewed journal Stem Cell Research of ...

View the full article

#65 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 18 October 2011 - 08:51 AM

Embryonic Stem-Cell Patents Infringe EU Law, Top Court Says
Bloomberg - 3 hours ago
By Stephanie Bodoni - Tue Oct 18 11:11:37 GMT 2011 The European Union's highest court said that stem-cell research involving human embryos can't be patented, in a ruling that scientists called ...

View the full article

#66 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 18 October 2011 - 08:51 AM

Embryonic Stem-Cell Patents Infringe EU Law, Top Court Says
Bloomberg - 20 hours ago
By Stephanie Bodoni - Tue Oct 18 08:28:17 GMT 2011 Patent protection for stem-cell research methods that involve cells from human embryos is not possible under European Union law, the region's ...

View the full article

#67 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 20 October 2011 - 12:01 AM

Mesoblast Limited (ASX:MSB) Received Licensing Executives Society 2011 Deals of Distinction™ Award
Asia Business News - 2 hours ago
Melbourne, Oct 20, 2011 (ABN Newswire) - Mesoblast Limited (ASX:MSB) and its strategic alliance partner Cephalon Inc. (NASDAQ:CEPH) were today awarded the Licensing Executives Society (USA and ...

View the full article

#68 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 23 October 2011 - 10:45 PM

Mesoblast Limited (ASX:MSB) Cleared to Begin First Phase 2 Clinical Trial for Eye Diseases
Asia Business News - 2 hours ago
Melbourne, Oct 24, 2011 (ABN Newswire) - Regenerative medicine company Mesoblast Limited (ASX:MSB) (PINK:MBLTY) today announced that it has received regulatory clearance from the Singapore Health ...
Mesoblast cleared for eye testing - Finance News Network

View the full article

#69 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 25 October 2011 - 12:49 PM

BioTime CEO Michael D. West To Present Keynote Address At Translational Strategies For Tissue Engineering Conference
TheStreet.com - 2 hours ago
By Business Wire 10/25/11 - 08:45 AM EDT BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief ...

View the full article

#70 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 26 October 2011 - 05:55 PM

Mesoblast Cleared to Begin First Phase 2 Clinical Trial for Eye Diseases
PR-USA.net - 1 hour ago
Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase ...

View the full article

#71 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 26 October 2011 - 05:55 PM

Mesoblast Cleared to Begin First Phase 2 Clinical Trial for Eye Diseases
PR-USA.net - 19 hours ago
Regenerative medicine company Mesoblast Limited (ASX: MSB) today announced that it has received regulatory clearance from the Singapore Health Sciences Authority (HSA) to commence the first Phase ...

View the full article

#72 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 28 October 2011 - 03:26 AM

Australia Stocks: Amcor, Coalspur, Fairfax, Macquarie, Mesoblast
BusinessWeek - 3 hours ago
By Nichola Saminather Oct. 28 (Bloomberg) -- Australia's S&P/ASX 200 Index climbed 0.7 percent to 4379.10 at 12:53 pm in Sydney. New Zealand's NZX 50 Index gained 1.2 percent to 3342.25 in ...

View the full article

#73 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 29 October 2011 - 06:38 PM

BioTime CEO Michael D. West to Present at Stem Cells USA & Regenerative Medicine Congress 2011
Benzinga - 2 hours ago
BioTime, Inc. (NYSE Amex:BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D ...

View the full article

#74 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 29 October 2011 - 06:38 PM

BioTime CEO Dr. Michael West to Present at 2011 World Stem Cell Summit
Benzinga - 6 hours ago
BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D ...

View the full article

#75 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 31 October 2011 - 02:29 AM

Market Watch: Mesoblast shares down 14%
Australian Life Scientist - 2 hours ago
Mesoblast (ASX:MSB) has seen its share price drop 14% in the last two days after being downgraded to "underperform" by Macquarie Research. The share price of stem cell specialists Mesoblast (ASX ...

View the full article

#76 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 08 November 2011 - 09:35 PM

BioTime Announces Third Quarter 2011 Financial Results and Recent Corporate Accomplishments
MarketWatch - 1 hour ago
ALAMEDA, Calif., Nov 08, 2011 (BUSINESS WIRE) -- BioTime, Inc. /quotes/zigman/219441/quotes/nls/btx BTX -0.22% , a biotechnology company that develops and markets products in the field of ...
10-Q: BIOTIME INC - Middle East North Africa Financial Network

View the full article

#77 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 08 November 2011 - 10:10 PM

10-Q: BIOTIME INC
Middle East North Africa Financial Network - 14 hours ago
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations We are a biotechnology company engaged in two areas of biomedical ...

View the full article

#78 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 09 November 2011 - 10:17 AM

Closing Zalicus Short Position: A Lesson In Getting The Timing Right
Seeking Alpha - 2 hours ago
I am closing my recommendation to short Zalicus (ZLCS), which was issued on July 6th, when the stock traded at 2.60. The stock closed at 1.16, -55% from my short recommendation. It's important to ...

View the full article

#79 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 09 November 2011 - 10:13 PM

Mesoblast Limited (ASX:MSB) Reports Positive Results Using Intravenously Injected Adult Stem Cells for Type 2 Diabetes
ABN Newswire - 1 hour ago
Melbourne, Nov 10, 2011 (ABN Newswire) - Regenerative medicine company, Mesoblast Limited (ASX:MSB), today announced that a single intravenous injection of its proprietary adult stem cells ...
Positive Results Using Adult Stem Cells for Type 2 Diabetes - irasia.com

View the full article

#80 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 November 2011 - 10:44 AM

VistaGen Therapeutics Represents Growing Field Of Cell-Based Therapy
Seeking Alpha - 13 hours ago
Note: We have received monetary compensation to perform investor relations services and increase investor awareness for VistaGen Therapeutics (VSTA.OB). Readers should be aware that this ...

View the full article

#81 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 11 November 2011 - 12:21 PM

Big Pharma Slowly Enters Stem Cell Therapy Game
Seeking Alpha - 12 hours ago
Having been somewhat non-committal regarding stem cell research in the past, big pharma's gradual investment in stem cell based biotechnologies indicates a significant, although slow paced, shift ...

View the full article

#82 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 14 November 2011 - 01:45 PM

BioTime Cell Information Now Available in GeneCards®
MarketWatch - 1 hour ago
ALAMEDA, Calif. & CAMBRIDGE, Mass., Nov 14, 2011 (BUSINESS WIRE) -- BioTime, Inc. /quotes/zigman/219441/quotes/nls/btx BTX -1.14% and XenneX, Inc. today announced the inclusion of cell ...
BioTime Cell Information Now Available In GeneCards® - TheStreet.com
BIOTIME, INC.: BioTime Cell Information Now Available in GeneCards® - 4-traders
SunHerald.com

View the full article

#83 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 14 November 2011 - 02:02 PM

Mesoblast stem cells work in heart failure trial
Reuters - 1 hour ago
ORLANDO, Fla (Reuters) - Stem cell therapy from Australia's Mesoblast Ltd was well tolerated and showed real promise in treating heart failure patients, according to data from a small mid-stage ...

View the full article

#84 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 14 November 2011 - 10:09 PM

sector news

#85 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 14 November 2011 - 11:55 PM

Mesoblast Says Revascor Reduced Cardiac Mortality At Follow-up Of 22 Months
RTT News - 12 hours ago
(RTTNews) - Mesoblast Limited (MBLTY.PK: News ) Monday said its proprietary Mesenchymal Precursor Cell product for cardiovascular diseases, Revascor, demonstrated significant reduction in cardiac ...

View the full article

#86 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 15 November 2011 - 07:06 PM

The Beneficiaries of Geron's Exit From Stem Cell Therapy
Seeking Alpha - 52 minutes ago
Geron Corporation (GERN) said on Monday that the company would be discontinuing their stem cell programs to focus on developing "first-in-class oncology" products - a decision that did not sit ...

View the full article

#87 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 17 November 2011 - 11:07 PM

Stem cell therapy for heart failure: two studies two successes
News-Medical.net - 18 hours ago
By Dr Ananya Mandal, MD The Center for Disease Control and Prevention says that heart failure affects nearly 6 million Americans leading to considerable risk of death, diminished quality of like ...

View the full article

#88 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 18 November 2011 - 04:44 PM

After Geron, Stem Cells’ New Saviors
Daily Beast - 1 hour ago
The biotech Geron may have abandoned its famous effort to treat paralyzed patients with stem cells—but two rivals are swooping in to do groundbreaking trials, Sharon Begley reports. So far, their ...

View the full article

#89 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 19 November 2011 - 05:21 PM

Only The Stem Cell News Biased Media Sees Fit to Print
First Things - 1 hour ago
Remember when Ron Reagan nonsense speech about embryonic stem cell research (actually human cloning research) at the 2004 Democratic Convention? Media swooned at the garbage and the hype (eg ...

View the full article

#90 ImmInst

  • Admin, Director robot
  • 2,350 posts
  • 72

Posted 21 November 2011 - 11:23 PM

Positive Outcome From FDA Meeting For Type 2 Diabetes Clinical Program Using Intravenous Delivery of Mesoblast Limited (ASX:MSB) Proprietary Adult Stem Cells
ABN Newswire - 2 hours ago
Melbourne, Nov 22, 2011 (ABN Newswire) - Global regenerative medicine company, Mesoblast Limited (ASX:MSB), today announced that it has reached agreement with the United States Food and Drug ...
Positive Outcome from FDA Meeting for Diabetes Program - irasia.com

View the full article





Also tagged with one or more of these keywords: economics, regenerative medicine, stemells, tissue engineering, regmed

1 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users


    Bing (1)